Abstract:

The aim has been spread throughout the world since December 2019. So far, we have very little evidence about maternal or perinatal results. In this study, we aimed at comparing pregnancies with severe and mild-mediate COVID-19 symptoms in terms of maternal and perinatal results. Method Working Group consisted of pregnancies with severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) symptoms, which were addressed to our third stage center and diagnosed. Patients were divided into two groups in the form of severe and non- severe and pregnancies that were determined to be in the group of severe diseases were hospitalized. The patient's routine follow-up continued and maternal and perinatal results were recorded. A total of 52 patients were included in the study, of which 59. In 6 were slight-mediate severity and 40.4 percent were severe diseases. During the diagnosis of COVID-19, the gestational age was higher in patients with severe symptoms than in patients with slight and medium severity symptoms (median: 20,5 vs 28.0, p=0.048 respectively). There was no difference between these two groups in terms of maternal and perinatal results. Despite the increasing number of published studies on COVID-19 in pregnancy, there is not enough quality data to find out about the severity of COVID-19 in symptomatic pregnancies and the maternal and neonatal outcomes. In our study, there was no difference in the direction of maternal and perinatal outcomes between the slight-mediate-intensity symptomatic group and the severe symptomatic group.

Keywords: